Mogamulizumab

Mogamulizumab
Mogamulizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target CCR4
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 1159266-37-1 N
ATC code None
Chemical data
Formula C6520H10072N1736O2020S42 
Mol. mass 146.44 kDa
 N(what is this?)  (verify)

Mogamulizumab is a humanized monoclonal antibody designed for the treatment of cancers.

Mogamulizumab was developed by Kyowa Hakko Kirin Co., Ltd.[1]

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Mogamulizumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/mogamulizumab.pdf. 
v · d · eMonoclonal antibodies for the immune system
Immune system ("-l(i[m])-")
Human ("-limu-")

immunosuppression: Adalimumab • Atorolimumab • Brodalumab • Carlumab • Fresolimumab • Golimumab • Lerdelimumab • Mavrilimumab • Metelimumab • Morolimumab • Namilumab • Oxelumab • Sarilumab • Sifalimumab • Tabalumab • Urelumab

immune activation: Ipilimumab • Tremelimumab

other: Bertilimumab • Zanolimumab
Mouse ("-limo-")
Chimeric ("-lixi-")
Humanized ("-lizu-")
immunosuppressive: Aselizumab • Apolizumab • Benralizumab† • Cedelizumab • Certolizumab pegol • Daclizumab • Eculizumab • Efalizumab • Epratuzumab • Erlizumab • Etrolizumab • Fontolizumab • Itolizumab • Mepolizumab • Mogamulizumab • Natalizumab • Ocrelizumab • Omalizumab • Ozoralizumab • Pascolizumab • Pateclizumab • Pexelizumab • PRO 140† • Reslizumab • Rontalizumab • Rovelizumab • Ruplizumab • Samalizumab • Siplizumab • Talizumab • Teplizumab • Tocilizumab • Toralizumab • Tregalizumab • Vatelizumab • Vedolizumab • Visilizumab • TGN1412§
non-immunosuppressive: Ibalizumab†
Chimeric + humanized
("-lixizu-")
Interleukin ("-k(i[n])-")
Human ("-kinu-")
Briakinumab • Canakinumab • Fezakinumab • Secukinumab • Sirukumab • Tralokinumab • Ustekinumab
Humanized ("-kizu-", "-kinzu-")
Anrukinzumab • Enokizumab • Gevokizumab • Ixekizumab • Lebrikizumab • Olokizumab
Inflammatory lesions ("-les-")
Mouse ("-leso-")
Besilesomab • Fanolesomab‡ • Lemalesomab • Sulesomab

M: LMC

cell/phys/auag/auab/comp, igrc

imdf/ipig/hyps/tumr

proc, drug(L3/4)


Stub icon This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.